http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110237132-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-638 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110237132-B |
| titleOfInvention | Kidney-tonifying and lipid-lowering medicine, preparation method and application thereof |
| abstract | The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a kidney-tonifying and lipid-lowering medicine, which comprises the following active ingredients in parts by weight: 15-20 parts of glossy privet fruit, 15-30 parts of eucommia bark, 20-30 parts of kudzu root, 10-30 parts of hawthorn, 10-20 parts of salvia miltiorrhiza and 10-15 parts of dried orange peel. The invention also provides a preparation method and application of the kidney-tonifying and lipid-lowering medicine. The kidney-tonifying and lipid-lowering medicine disclosed by the invention treats the dyslipidemia of climacteric women by a treatment method mainly comprising the functions of tonifying kidney, removing blood stasis, reducing phlegm and lowering lipid, can improve the blood lipid level of patients, can prevent and treat the dyslipidemia of the climacteric women by regulating follicle-stimulating hormone and receptors thereof and improving the functions of vascular endothelial progenitor cells, and has good treatment effect and reliable safety. |
| priorityDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.